| Feb 28, 2023 |
Mar 2, 2023 |
TransMedics Group, Inc.
|
Director |
Buy |
100.0
|
+242,477
|
401.35%
|
✗
|
$19.3M |
| Nov 29, 2021 |
Nov 30, 2021 |
TransMedics Group, Inc.
|
Director |
Buy |
100.0
|
+100,000
|
49.29%
|
✗
|
$2.3M |
| May 6, 2019 |
May 6, 2019 |
TransMedics Group, Inc.
|
Director |
Buy |
20.0
|
-893,743
|
-68.86%
|
✗
|
$533.3K |
| May 16, 2017 |
May 16, 2017 |
Cartesian Therapeutics, Inc.
|
Director |
Sell |
17.5
|
-266,795
|
-31.26%
|
✗
|
$3.7M |
| Sep 22, 2016 |
Sep 26, 2016 |
Carisma Therapeutics Inc.
|
10% Owner |
Sell |
17.5
|
-443,422
|
-14.78%
|
✗
|
$1.4M |
| Sep 19, 2016 |
Sep 21, 2016 |
Carisma Therapeutics Inc.
|
10% Owner |
Sell |
17.5
|
-386,340
|
-9.62%
|
✗
|
$1.4M |
| Sep 14, 2016 |
Sep 16, 2016 |
Carisma Therapeutics Inc.
|
10% Owner |
Sell |
22.5
|
-46,692
|
-1.68%
|
✗
|
$195.1K |
| Sep 6, 2016 |
Sep 8, 2016 |
Carisma Therapeutics Inc.
|
10% Owner |
Sell |
20.0
|
-129,497
|
-1.93%
|
✗
|
$588.3K |
| May 25, 2016 |
May 27, 2016 |
Seres Therapeutics, Inc.
|
10% Owner |
Sell |
15.0
|
-2,000,000
|
-11.99%
|
✗
|
$27.6M |
| Feb 11, 2014 |
Feb 13, 2014 |
Carisma Therapeutics Inc.
|
10% Owner |
Buy |
100.0
|
+378,729
|
12.65%
|
✗
|
$3.8M |